Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
IPO Year: 2001
Exchange: NASDAQ
Website: aligntech.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/10/2024 | Hold | Needham | |
| 2/26/2024 | $310.00 | Market Perform | Leerink Partners |
| 12/11/2023 | $197.00 | Neutral → Sell | Goldman |
| 10/27/2023 | $200.00 | Buy → Neutral | UBS |
| 2/2/2023 | $165.00 → $307.00 | Sell → Neutral | Goldman |
| 7/28/2022 | $380.00 → $250.00 | Buy → Sell | Goldman |
| 2/3/2022 | $782.00 → $722.00 | Outperform | Credit Suisse |
| 2/3/2022 | $675.00 → $625.00 | Buy | Stifel |
| 1/31/2022 | $880.00 → $620.00 | Neutral → Buy | UBS |
| 1/31/2022 | $575.00 | Overweight | Morgan Stanley |
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that after nearly six years with Align, Yuval Shaked, executive vice president and managing director of iTero scanner and services, has decided to leave the company for personal reasons and spend more time with his family. He will remain with Align and continue as a member of Align Technology President and CEO Joe Hogan's staff supporting strategic initiatives and programs through 2023. Mr. Shaked will transition
TEMPE, Ariz., SAN JOSE, Calif., and SINGAPORE, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Raj Pudipeddi, Align Technology chief product and marketing officer, and senior vice president will assume additional responsibility for the commercial organization in the Asia Pacific region as managing director, effective immediately, succeeding Julie Tay, Align Technology senior vice president and managing director, Asia Pacifi
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)
Stifel analyst Jonathan Block maintains Align Tech (NASDAQ:ALGN) with a Buy and lowers the price target from $400 to $350.
Piper Sandler analyst Jason Bednar maintains Align Tech (NASDAQ:ALGN) with a Overweight and lowers the price target from $330 to $315.
Align Technology Inc (NASDAQ:ALGN) shares are trading lower in Wednesday’s after-hours session after the company reported second-quarter financial results and issued soft guidance. Q2 Revenue: $1.03 billion, versus estimates of $1.04 billion Q2 EPS: $2.41, versus estimates of $2.30 Total revenue was up 2.6% on a year-over-year basis after being unfavorably impacted by foreign exchange of approximately $11.6 million or 1.1%. Align, which sells the well-known Invisalign clear aligner system, said clear aligner revenues were down 0.1% year-over-year to $831.7 million in the quarter. Imaging systems and CAD/CAM services revenue totaled $196.8 million, up 16.1% on a year-over-yea
Third quarter 2024 outlook:For Q3'24, we are providing the following business outlook:•We expect our Q3 worldwide revenues to be in the range of $980M to $1,000M•We expect Clear Aligner volume to be down sequentially as a result of Q3 seasonality, and Clear Aligner ASPs to be down sequentially, primarily due to foreign exchange and product mix•We also expect Systems and Services revenues to be down sequentially because of Q3 seasonality•We expect our Q3'24 GAAP operating margin to be below Q3'23 GAAP operating margin and Q3'24 non-GAAP operating margin to be flat to Q3'23 non-GAAP operating margin
Align Tech (NASDAQ:ALGN) reported quarterly earnings of $2.41 per share which beat the analyst consensus estimate of $2.30 by 4.78 percent. The company reported quarterly sales of $1.03 billion which missed the analyst consensus estimate of $1.04 billion by 0.71 percent. This is a 2.69 percent increase over sales of $1.00 billion the same period last year.
Early Access Registration Opens Today; Available To Customers Later This Year
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. Here's the list of options activity happening in today's session: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume BSX PUT SWEEP BEARISH 08/16/24 $75.00 $68.9K 5.5K 2.1K MRNA CALL SWEEP NEUTRAL 11/15/24 $170.00 $121.
Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Align Tech (NASDAQ:ALGN) in the last three months. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 7 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 1 0 0 0 2M Ago 0 2 0 0 0 3M Ago 0 3 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $341.43, a high estimate of $375.00, and a low estimate of $300.00. A negative shift in sentiment is evident as ana
10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
SD - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)
Invisalign® Palatal Expanders offer doctors a removeable, safe, and clinically effective alternative to traditional palatal expanders. With Invisalign First™ aligners and Invisalign® Palatal Expanders, Align Technology now provides doctors with a full early intervention treatment solution, including both skeletal (orthopedic) and dental (orthodontic) arch expansion. The Invisalign Palatal Expander System has also completed registration with the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA). Both approvals are for broad patient applicability, including growing children, teens, and adults (with surgery or other techniques). Align Technology, Inc. ("Ali
Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from the 2024 Invisalign Ortho Summit, Align's premier clinical education and peer-to-peer networking experience designed to help doctors transform and grow their practice with Invisalign® clear aligners, iTero scanners, and the Align™ Digital Platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241111839157/en/ The 2024 Invisalig
2025 Grant Application Process Now Open for Up to $300,000 in Funding Align Technology, Inc. (NASDAQ:ALGN) today announced the opening of its 2025 Annual Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of orthodontics and dentistry. Align Technology's Research Award Program has funded approximately $3.75 million in research since the program's inception in 2010. "This program continues to generate much scientific and clinical interest from university researchers around the glo
Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following upcoming financial conferences. The presentations, as noted below, will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the website for approximately three months. Conference: UBS Global Healthcare Conference Date: Thursday, November 1
Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $275 million of Align's common stock through open market repurchases under Align's $1.0 billion stock repurchase program that was approved by Align's Board of Directors in January 2023. "Today's announcement of our intention to repurchase $275 million of our common stock through open market repurchases reflects the strength of our balance sheet and cash flow generation,
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced Frank Quinn, formerly Align vice president and general manager of the United States, will rejoin the company as executive vice president and managing director of the Americas region, reporting to Joe Hogan, Align president and CEO. As part of the global organizational restructuring plan that the company announced separately today, Raj Pudipeddi's position as executive vice president and managing director of the Am
Company expects to repurchase up to $275.0 million of its common stock beginning in Q4'24 Q3'24 total revenues of $977.9 million, increased 1.8% year-over-year, and Q3'24 diluted net income per share was $1.55, or $2.35 on a non-GAAP diluted basis Q3'24 total revenues were unfavorably impacted by foreign exchange by approximately $14.6 million year-over-year(1), and were not significantly impacted sequentially Q3'24 operating income of $162.3 million and operating margin of 16.6%, non-GAAP operating margin of 22.1% Q3'24 GAAP operating margin was unfavorably impacted by foreign exchange by approximately 0.8 points year-over-year(1), and was not significantly impacted sequentially
Align™ Oral Health Suite with new comparison tools that aid in multi-modality assessments and personalized oral health reports Invisalign® Outcome Simulator Pro with Multiple Treatment Simulation to drive chairside patient education about treatment options iTero™ Design Suite with intuitive design capabilities for in-practice 3D printing, now commercially available in select markets Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced iTero intraoral scanner
Helps patients visually understand treatment choices utilizing an iTero™ scanner at chairside for enhanced patient education Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for restorative dentistry, today announced the release of the next innovation of Invisalign Smile Architect software, now with Multiple Treatment Plans allowing doctors to visually compare and modify orthodontic only and ortho restorative treatment plans side-by-side. The Multiple Treatment Plans are integrated into ClinCheck® treatment planning s
Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2024 financial results on Wednesday, October 23, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be
Company expects to repurchase up to $275.0 million of its common stock beginning in Q4'24 Q3'24 total revenues of $977.9 million, increased 1.8% year-over-year, and Q3'24 diluted net income per share was $1.55, or $2.35 on a non-GAAP diluted basis Q3'24 total revenues were unfavorably impacted by foreign exchange by approximately $14.6 million year-over-year(1), and were not significantly impacted sequentially Q3'24 operating income of $162.3 million and operating margin of 16.6%, non-GAAP operating margin of 22.1% Q3'24 GAAP operating margin was unfavorably impacted by foreign exchange by approximately 0.8 points year-over-year(1), and was not significantly impacted sequentially
Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2024 financial results on Wednesday, October 23, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2024 financial results on Wednesday, July 24, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be
Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2024 financial results on Wednesday, April 24, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will beg
Unveils Next-Generation iTero Lumina™ Intraoral Scanner Featuring a 3X Wider Field of Capture1 in a 50% Smaller Wand2 that Delivers Faster Scanning, Higher Accuracy3, and Superior Visualization4 for Greater Practice Efficiency Q4 and FY2023 total revenues up 6.1% year over year and up 3.4% year over year, respectively Major 2023 milestones: 17 million Invisalign® patients, 4 million Vivera™ retainers, and 100 thousand iTero™ scanner units 2023 total revenues of $3.9 billion, Clear Aligner revenues of $3.2 billion and Systems and Services revenues of $662.9 million 2023 revenues were unfavorably impacted by foreign exchange of approximately $36.3 million compared to 2022(5) 2023
Align continues to innovate and invest in technologies that enable the next generation of direct 3D printed products, thus helping us create more sustainable and efficient solutions. Align Technology, Inc. (Align) (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has completed the acquisition of privately-held Cubicure GmbH, a pioneer in direct 3D printing solutions for polymer additive manufacturing that develops, produces, and distributes innovative materials, equipment, and
Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and 2023 financial results on Wednesday, January 31, 2024, after the close of market. Financial results will be released at 4:00 p.m. ET (2:00 p.m. MT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call
NEW YORK, Dec. 08, 2023 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NASDAQ:NDX), which will become effective prior to market open on Monday, December 18, 2023. The following six companies will be added to the Index: CDW Corporation (NASDAQ:CDW), Coca-Cola Europacific Partners plc (NASDAQ:CCEP), DoorDash, Inc. (NASDAQ:DASH), MongoDB, Inc. (NASDAQ:MDB), Roper Technologies, Inc. (NASDAQ:ROP), and Splunk Inc. (NASDAQ:SPLK). The Nasdaq-100 Index® is composed of 100 of the largest non-financial companies listed on The Nasdaq Stock Market® and dates to January 1985 when it was launched along with the Nasdaq Fina
Q3'23 record clear aligner shipments to teenage patients increased 9.9% sequentially and 8.4% year over year, driven by continued strength from Invisalign First™ Company expects to repurchase up to $250.0 million of its common stock in Q4'23 Q3'23 total revenues of $960.2 million, increased 7.8% year-over-year, and diluted net income per share of $1.58, non-GAAP diluted net income per share of $2.14 Q3'23 revenues were unfavorably impacted by foreign exchange of approximately $2.7 million sequentially and favorably impacted by approximately $4.2 million year-over-year(1) Q3'23 operating income of $166.3 million and operating margin of 17.3%, non-GAAP operating margin of 21.8%
Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report third quarter 2023 financial results on Wednesday, October 25, 2023, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will b
Needham initiated coverage of Align Tech with a rating of Hold
Leerink Partners initiated coverage of Align Tech with a rating of Market Perform and set a new price target of $310.00
Goldman downgraded Align Tech from Neutral to Sell and set a new price target of $197.00
UBS downgraded Align Tech from Buy to Neutral and set a new price target of $200.00
Goldman upgraded Align Tech from Sell to Neutral and set a new price target of $307.00 from $165.00 previously
Goldman downgraded Align Tech from Buy to Sell and set a new price target of $250.00 from $380.00 previously
Credit Suisse reiterated coverage of Align Tech with a rating of Outperform and set a new price target of $722.00 from $782.00 previously
Stifel reiterated coverage of Align Tech with a rating of Buy and set a new price target of $625.00 from $675.00 previously
UBS upgraded Align Tech from Neutral to Buy and set a new price target of $620.00 from $880.00 previously
Morgan Stanley initiated coverage of Align Tech with a rating of Overweight and set a new price target of $575.00
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)
SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)